This is unpublished

Jeffrey T.
Schouten
MD
JD

Jeffrey T. Schouten

(206) 295-5407

325 Ninth Avenue, Box 359929 Seattle, WA 98104
He/Him/His
Faculty
Infectious Diseases
Pinned
Academic
Clinical Associate Professor, Department of Medicine, Division of Allergy & Infectious Diseases
Clinical Associate Professor, Department of Surgery
Professional
Attending Physician
Sites of Practice
Harborview Medical Center

related links

UW department of medicine
UW department of surgery
fred hutchinson cancer research center

bio

Jeffrey Schouten, MD, JD, AAHIVE is a Clinical Associate Professor Emeritus in the Surgery Department and Allergy and Infectious Diseases Divisions of the University Of Washington School Of Medicine. He is an attending physician at the Madison Clinic at Harborview Medical Center and founded the Anal Dysplasia Clinic at Harborview in February 2012. He is certified to perform high resolution anoscopy by the AIDS Malignancy Consortium for their research trials and performs ablation of high grade anal dysplasia as well. He is a former general surgeon with a focus on surgical oncology. He has been involved in HIV clinical research and HIV primary care for more than two decades. As a co-investigator at the University of Washington HIV positive Research Unit since 2002, he has served as local PI on many protocols, on many international protocol teams as an investigator and as a vice-chair on two protocols (A5200 and A5271), as well as several terms on ACTG scientific review committees. Jeff has had a long commitment to HIV clinical research, complications of HIV treatment and the high priority area of eradication or functional cure of HIV. He is the former Director of the Office of HIV/AIDS Coordination (HANC) serving from 2008-2022, at the Fred Hutchinson Cancer Center, and currently serves as a consultant to HANC.
 

research interests

  • Anal cancer prevention: screening and treatment of HPV-related high grade anal dysplasia
  • Complications of HIV infection

clinical interests

  • HIV
  • Anal dysplasia
  • Anal cancer

Education & Training

1970-73  BS, Biology and Mathematics, Cum Laude, S.U.N.Y. at Albany, Albany, New York

1973-77  MD, S.U.N.Y. Downstate Medical Center, Cum Laude, Alpha Omega Alpha, Brooklyn, New York

1992-1996 JD, University of Washington School of Law, Seattle, Washington


Postgraduate Training:    

1977-1982: Residency: Department of Surgery, University of Texas Health Science Center, Parkland Memorial Hospital, Dallas, Texas

1980-1981: Fellowship: Fellow in Human Oncology and Surgery, University of Wisconsin Clinical Cancer Center, Madison, Wisconsin

 

publications

MyNCBI

 

Robertson KR, Jiang H, Kumwenda J, Supparatpinyo K, Marra CM, Berzins B, Hakim J, Sacktor N, Campbell TB, Schouten J, Mollan K, Tripathy S, Kumarasamy N, La Rosa A, Santos B, Silva MT, Kanyama C, Firhnhaber C, Murphy R, Hall C, Marcus C, Naini L, Masih R, Hosseinipour MC, Mngqibisa R, Badal-Faesen S, Yosief S, Vecchio A, Nair A; AIDS Clinical Trials Group. HIV Associated Neurocognitive Impairment in Diverse Resource Limited Settings. Clin Infect Dis. (2019) May 2;68(10):1733-1738. [original work]

Stankiewicz Karita H, Hauge K, Magaret A, Mao C, Schouten J, Grieco V, Xi LF, Galloway D, Madeleine MM, Wald A. Effect of Human Papillomavirus Vaccine to Interrupt Recurrence of Vulvar and Anal Neoplasia (VIVA): A Trial Protocol. JAMA Network Open. 2019;2(4) [original work]

Vecchio AC, Marra CM, Schouten J, Jiang H, Kumwenda J, Supparatpinyo K, Hakim J, Sacktor N,  Campbell TB, Tripathy S, Kumarasamy N, La Rosa A, Santos B, Silva MT, Kanyama C, Firnhaber C,  Hosseinipour MC, Mngqibisa R, Hall C, Cinque P, Robertson K and the AIDS Clinical Trials Group 5199 and 5271 study team. Distal Sensory Peripheral Neuropathy in HIV-1 Positive Individuals Before and After ART Initiation in Diverse Resource-Limited Settings. Clinical Infectious Diseases, Volume 71, Issue 1, 1 July 2020, Pages 158–165.

Palefsky JM, Lee JY, Ph.D., Jay N, R.N., Ph.D., Goldstone SE, M.D., Darragh TM, M.D., Dunlevy HA, M.D., Rosa-Cunha I, M.D., Arons A, M.P.H., Pugliese JC, M.P.H., Vena D, N.D., Sparano JA, M.D.,  Wilkin TJ, M.D., Bucher G, M.D., Stier EA, M.D., Tirado Gomez M, M.D., Flowers L, M.D., M.P.H., Barroso LF, M.D., Mitsuyasu RT, M.D., Lensing SY, M.S., Logan J, P.A., Aboulafia DM, M.D., Schouten JT, M.D., de la Ossa J, M.D., Levine R, M.D., Korman JD, M.D., Hagensee M, M.D., Ph.D., Atkinson TM, Ph.D., Einstein MH, M.D., Cracchiolo BM, M.D., Wiley D, Ph.D., R.N., Ellsworth GB, M.D., Brickman C, M.D., M.S.C.E., and Berry-Lawhorn JM, M.D.et al., for the ANCHOR Investigators Group. Treatment of Anal High-Grade Squamous Intraepithelial Lesions to Prevent Anal Cancer. N Engl J Med 2022; 386:2273-2282.